Background: Observational studies have suggested that low blood pressure and blood pressure variability may partially explain adverse neurological outcome after endovascular therapy with general anaesthesia (GA) for acute ischaemic stroke. The aim of this study was to further examine whether blood pressure related parameters during endovascular therapy are associated with neurological outcome. Methods: The GOLIATH trial randomised 128 patients to either GA or conscious sedation for endovascular therapy in acute ischaemic stroke. The primary outcome was 90 day modified Rankin Score. The haemodynamic protocol aimed at keeping the systolic blood pressure >140 mm Hg and mean blood pressure >70 mm Hg during the procedure. Blood pressure related parameters of interest included 20% reduction in mean blood pressure; mean blood pressure <70 mm Hg, <80 mm Hg, and <90 mm Hg, respectively; time with systolic blood pressure <140 mm Hg; procedural minimum and maximum mean and systolic blood pressure; mean blood pressure at the time of groin puncture; postreperfusion mean blood pressure; blood pressure variability; and use of vasopressors. Sensitivity analyses were performed in the subgroup of reperfused patients. Results: Procedural average mean and systolic blood pressures were higher in the conscious sedation group (P<0.001). The number of patients with mean blood pressure <70e90 mm Hg and systolic blood pressure <140 mm Hg, blood pressure variability, and use of vasopressors were all higher in the GA group (P<0.001). There was no statistically significant association between any of the examined blood pressure related parameters and the modified Rankin Score in the overall patient population, and in the subgroup of patients with full reperfusion. Conclusion: We found no statistically significant association between blood pressure related parameters during endovascular therapy and neurological outcome. Clinical trial registration: NCT 02317237.
Controversies exist about the optimal anaesthetic management during endovascular therapy (EVT) for acute ischaemic stroke. Observational studies and recent meta-analyses suggest that general anaesthesia (GA) compared with conscious sedation (CS) is associated with worse outcome in patients undergoing EVT for acute ischaemic stroke. 1e3 In contrast, three randomised trials demonstrated no significant difference in neurological outcome between patients treated under GA versus CS. 4e6 The differences in the findings between the observational studies and the trials are likely to reflect confounding by indication and hence selection bias. Nevertheless, questions remain regarding the optimal anaesthetic approach, as anaesthetic drugs influence blood pressure, and a number of observational studies have suggested that periprocedural haemodynamic management may contribute to the poor neurological outcome after GA. Consequently, the Society for Neuroscience in Anesthesiology and Critical Care recommended a systolic blood pressure (SBP) >140 mm Hg. 12 However, a detailed analysis of haemodynamic variables and their association with clinical outcomes has not previously been performed in a prospective setting with adherence to a haemodynamic protocol. In the GOLIATH (General or Local Anesthesia in Intra Arterial Therapy) trial, blood pressure was rigorously managed and recorded according to a blood pressure protocol where mean arterial blood pressure (MABP) and SBP simultaneously were aimed above 70 and 140 mm Hg, respectively. 13 In this pre-specified analysis 13 blood pressure variables from the GOLIATH trial were analysed with the aim to examine whether blood pressure parameters are associated with neurological outcome after EVT. It was hypothesised that haemodynamic variables were associated with 90-day neurological outcome.
Methods

Patients
The GOLIATH trial was a single-centre, prospective parallel group, open-label randomised controlled trial with blinded end point evaluation (PROBE design). 6 The study is registered in Clinical Trials (NCT02317237). Details concerning inclusion and exclusion criteria and patient screening have previously been reported. 6 Briefly, patients were included from March 2015 to February 2017. After meeting study entry criteria (including age !18 yr, National Institutes of Health Stroke Scale !10, initial infarct <70 ml, independently living, and groin puncture possible within 6 h from onset) patients with acute ischaemic stroke presenting with anterior circulation large vessel occlusion were randomised for EVT under either GA or CS; 128 patients were included in the trial. Sixty-five patients were randomised to GA and 63 patients allocated to CS. Four patients (6%) crossed over from CS to GA. These patients remained in the CS group for the statistical analysis according to the intention to treat principle. The local ethics committee accepted waiver of consent before randomisation because eligible patients typically were not able to give consent and treatment was time critical (record number 1-10-72-356-14.) Patients (or next of kin) were later required to give written consent in order to remain in the trial. (Only one patient refused to give postrandomisation consent as he did not want to undergo repeat magnetic resonance imaging scan.) There was no data safety monitoring board.
Anaesthesia and haemodynamic measurements
GA included rapid sequence induction with suxamethonium, alfentanil, and propofol followed by infusion of propofol and remifentanil. 13 Following tracheal intubation controlled ventilation was applied and normoventilation was attempted. Conscious sedation included a fentanyl bolus dose which was repeated if necessary and a low dose propofol infusion with the infusion rate adjusted at the discretion of the anaesthesiologist. 13 Periprocedural monitoring consisted of continuous electrocardiogram, pulse oximetry, and end-tidal carbon dioxide monitoring. An arterial catheter was inserted before induction for continuous invasive arterial blood pressure measurements. As previously described, blood pressure variables including SBP, diastolic blood pressure, and MABP were measured every minute throughout the procedure. 6 Immediately after termination of the procedure, the attending neuroanaesthesiologist calculated the time the patient was below the prespecified blood pressure thresholds (SBP<140 mm Hg, MABP<90 mm Hg, MABP<80 mm Hg, MABP<70 mm Hg) and manually recorded blood pressure measurements for every minute during the first 5 min followed by recording of measurements for every 5 min. Outcome measures and parameters
Neurological outcome was determined with the modified Rankin Score (mRS) after 90 days by an independent assessor blinded to randomisation. The mRS scale measures degree of disability and ranges from 0 (no symptoms) to 6 (dead). The entire distribution of the mRS (0e6 points) and the dichotomised mRS 0e2 vs 3e6 were defined as outcomes. 7, 8 The degree of reperfusion was determined by the modified Thrombolysis in Cerebral Infarction Score (mTICI) where mTICI 0e2A depicts poor reperfusion and mTICI 2B-3 successful reperfusion. 16 The following haemodynamic parameters were predefined in the GOLIATH study protocol. 
Statistical analysis
The association between the haemodynamic variables listed above and 90 day neurological outcome as determined by the mRS was studied. Categorical variables were compared using the c 2 test or Fisher's exact test and continuous variables were compared with either the t-test or ManneWhitney U test where appropriate. Analysis of ARV syst , ARV diast , and ARV MABP was performed with an unpaired t-test on log-transformed data. Statistical significance was determined at the 5% level. An ordinal logistic regression shift analysis was performed across the entire ordinal mRS scale (0e6) to compute odds ratios (OR) for any improvement in mRS. An additional logistic regression analysis was performed to assess the association between the haemodynamic parameters and a good clinical outcome defined as the mRS 0e2. Furthermore, because the failure to achieve reperfusion portends a poor outcome in the vast majority of cases, 17 it is conceivable that haemodynamic changes may have a greater influence on outcomes in reperfused patients. Therefore, we performed a post hoc sensitivity analysis wherein all outcome analyses were repeated in the subgroup of patients with successful reperfusion. Analyses were performed using STATA (version 12.0, StataCorp LP, College Station, TX, USA) and MedCalc software (version 14.12.0, Ostend, Belgium).
Results
Patient characteristics
Data concerning patient characteristics and comorbidity, and treatment-related data have previously been published.
6 Table 1 Anaesthetic and vasopressor doses. Doses are median (inter-quartile range). Prop/remi, propofol/remifentanil; Prop/fent, propofol/fentanyl. *P<0.001 Anaesthetics
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Briefly, the distribution of demographic data, premorbid mRS, comorbidities, number of patients receiving i.v. tissue plasminogen activator pretreatment, lesion location, time from onset to qualifying magnetic resonance imaging, and EVT approach was similar between the two groups.
Anaesthetics, vasopressors, and ventilation
Anaesthetic and vasopressor doses are shown in Table 1 . Median end-tidal CO 2 in the GA group was 4.4 kPa (interquartile range, 4.2e4.8 kPa).
Comparison of haemodynamic variables
Periprocedural MABP values in the GA and CS group are presented in Fig. 1 . MABP was significantly lower in the GA group until approximately 15 min after anaesthesia induction. There were no differences in MABP at the time of reperfusion and at termination of the EVT procedure. A comparison of blood pressure variables is presented in Haemodynamic parameters and influence on outcome
There was no statistically significant association between any of the assessed haemodynamic parameters, including both dichotomous and continuous parameters, and the neurological outcome in the overall population (Table 3 ) and subpopulation of patients with full reperfusion (Table 4) . This was the case both when examining the chance of any neurological improvement on the mRS scale and when examining the chance of a good neurological outcome, defined as having no or only very mild impairments (mRS 2).
Discussion
No statistically significant associations were found between blood pressure variables and neurological outcome in this secondary analysis of GOLIATH trial data. To our knowledge, this is the first report examining the association of haemodynamic management on outcome in patients with acute ischaemic stroke undergoing EVT, using prospectively collected data from a randomised trial. As expected, in the GA group, the MABP was lower during the first approximately 15 min of the procedure. In addition patients in this group had lower procedural SBP, procedural MABP, frequency of episodes with SBP<140 mm Hg, MABP<90 mm Hg, MABP<80 mm Hg, and MABP<70 mm Hg and higher blood pressure variability; but these blood pressure 6 This is in agreement with the findings from two previous randomised trials, which also reported no difference in the primary outcome parameters (90 day mRS 0e2 and National Institutes for Health Stroke Scale at 24 h) between the GA and CS groups. 4, 5 However, as secondary outcome parameters, both the SIESTA and GOLIATH studies reported higher rates of good outcome at 90 days in the GA groups. 5, 6 The findings from the three randomised trials are in contrast to retrospective analyses, which found less favourable outcomes among patients who underwent GA. 1,3,9,18e20 Meticulous haemodynamic management in the randomised studies may partially account for differences in findings between these trials and the retrospective studies. In the GOLIATH study blood pressure was meticulously managed according to two criteria. First, the Society for Neuroscience in Anesthesiology and Critical Care recommends a SBP>140 mm Hg based on the findings by Davis and colleagues. 9 ,12 Second, we also aimed for MABP>70 mm Hg as suggested by Whalin and colleagues, who reported poor outcomes below this threshold. 14 Corresponding SBP targets were also applied in the SIESTA and AnStroke trials, which both targeted a minimum SBP threshold of 140 mm Hg. 4, 5 Haemodynamic instability is most likely to occur during the anaesthesia induction phase and early part of the EVT procedure, and should be regarded within the context of the anaesthetic management. In the GA group, the reported propofol induction and maintenance dose in combination with remifentanil correlate with recommended doses for older adults or ASA III/IV patients. 21 Further, the propofol dosage regimen, with and without supplementary fentanyl in the CS group, is in agreement with recommended doses for monitored anaesthesia care. 21 Although vasopressors were required in 98% of the patients in the GA group, both anaesthetic regimens were carefully maintained within recommended guidelines and with consideration of patient age and comorbidity. Similar to the AnStroke study we found lower blood pressures in the GA group during the initial part of the procedure without any differences at the time of reperfusion. 4 The SIESTA Table 3 Association between haemodynamic parameters and neurological outcome in patients with acute ischaemic stroke undergoing endovascular therapy. Results presented for the entire study population. ARV MABP , MABP average real variability; DMABP, difference between baseline MABP and average of all MABP values throughout the procedure; CI, confidence interval; MABP, mean arterial blood pressure; mRS, modified Rankin Score; OR, odds ratio; SBP, systolic blood pressure. * An ordinal logistic regression shift analysis was performed across the entire ordinal mRS scale (0e6) to compute OR for any improvement in mRS. investigators did not report detailed peri-procedural blood pressure values but found a higher incidence of procedural hypotensive episodes with SBP<120 mm Hg (23% vs 13%) in the GA group. 5 However, similar to the GOLIATH study, the SIESTA procedure mean SBPs were maintained >140 mm Hg. 5 The
AnStroke investigators did not report peri-procedural SBPs but they managed to maintain mean procedure MABP>90 mm Hg in both groups with few episodes of decrease in MABP>40%. 4 Collectively, the findings from the recent single centre randomised trials suggest that meticulous haemodynamic management with the aim to avoid SBP<140 mm Hg might be an important component in preventing poor outcome after EVT.
4e6
Several retrospective analyses have suggested hypotension and unstable haemodynamics as mechanisms responsible for the negative outcome associated with GA. 7À9,11,14,22 Specifically, decreases in blood pressure below certain thresholds, 9, 14 reduction in blood pressure of different magnitudes, 7, 22 and measures of blood pressure variability 8, 11 have all been reported to influence outcome. In this study the number of patients with episodes of SBP<140 mm Hg (94% vs 62%, P<0.0001) and MABP<70 mm Hg (35% vs16%, P ¼ 0.01) was higher in the GA group. However, in contrast to the studies by Davis and colleagues 9 and Whalin and colleagues, 14 recordings of SBP and MABP values below these targets did not appear to influence outcome. The finding in this study that the median time below these thresholds was similar in the GA and CS groups may account for this apparent discrepancy. Furthermore, although mean procedural SBP and MABP were lower in the GA group, these values were maintained over the previously mentioned specified targets for SBP and MABP. Interestingly, we found that patients in the CS group spent more time (min) with MABP<80 mm Hg compared with the GA group (20 vs 6 min, P ¼ 0.0045) with a similar trend for MABP<70 mm Hg (6.5 vs 2 min, P ¼ 0.09). This could possibly be related to less vasopressor use in the CS group (57% vs 98%, P<0.001), and may reflect a more relaxed attitude on the part of the attending anaesthesiologist to time spent below predefined blood pressure targets during CS.
Whalin and colleagues 22 identified a 10% reduction in MABP from baseline as a risk factor for poor outcome. This finding is in contrast to the GOLIATH study, where a 20% decrease in MABP was not associated with negative neurological outcome. 6 In the GOLIATH study we found that 88% of the patients in the GA group experienced a 20% decrease in MABP. 6 Treurniet and colleagues 11 reported that blood pressure variability measured as DMABP was associated with poor outcome. Contrary to these findings, we could not demonstrate an influence of DMABP and ARV on outcome, although these variables were different between the GA and CS groups. Thus, previously reported associations between haemodynamic measures poor neurological outcome from retrospective studies were not confirmed in our analyses of prospectively collected clinical trials data.
Study limitations
This study has several limitations. Patients were randomised to either GA or CS and not to different blood pressure protocols. Thus, the findings in this study should be confirmed in a randomised study targeting different blood pressures. The GOLIATH trial was a single-centre study and this may limit the generalisability of the findings. Other centres may lack specialised neuroanaesthesia competence and apply different approaches to anaesthesia and haemodynamic management. In the GOLIATH study, the choice of vasopressor (phenylephrine, ephedrine, or both) was at the discretion of the anaesthesiologist. However, phenylephrine and ephedrine are associated with different effects on brain oxygenation, and this difference may have influenced outcome and warrants further investigation. 23 Only i.v. anaesthetics were administered in the GA group, and haemodynamic changes may be different in patients anaesthetised with volatile anaesthetics.
In conclusion, with the applied haemodynamic protocol, we were unable to demonstrate any statistically significant influence of blood pressure variables on neurological outcome in patients undergoing EVT. This finding suggests that adherence to a haemodynamic protocol targeting SBP>140 mm Hg and MABP>70 mm Hg with limited and short episodes of BP values below these thresholds might be safe during both GA and CS for acute ischaemic stroke revascularisation.
